Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-41,298
Closed -$1.33M 3310
2017
Q2
$1.32M Buy
+41,298
New +$1.3M 0.03% 917
2017
Q1
Sell
-252,848
Closed -$7.97M 3233
2016
Q4
$7.79M Buy
252,848
+151,688
+150% +$4.63M 0.18% 110
2016
Q3
$3.25M Sell
101,160
-71,250
-41% -$2.38M 0.07% 436
2016
Q2
$5.76M Sell
172,410
-167,636
-49% -$5.35M 0.1% 256
2016
Q1
$9.56M Buy
340,046
+192,626
+131% +$5.5M 0.17% 130
2015
Q4
$4.51M Buy
147,420
+146,795
+23,487% +$4.62M 0.05% 539
2015
Q3
$19K Sell
625
-6,229
-91% -$200K ﹤0.01% 3518
2015
Q2
$218K Sell
6,854
-97,844
-93% -$3.19M ﹤0.01% 2658
2015
Q1
$3.46M Buy
104,698
+104,650
+218,021% +$3.33M 0.03% 762
2014
Q4
$1K Sell
48
-244
-84% -$7K ﹤0.01% 3897
2014
Q3
$8K Sell
292
-86,184
-100% -$2.42M ﹤0.01% 4080
2014
Q2
$2.44M Buy
86,476
+2,512
+3% +$71.6K 0.01% 1495
2014
Q1
$2.56M Buy
83,964
+43,381
+107% +$1.29M 0.01% 1308
2013
Q4
$1.18M Buy
40,583
+37,976
+1,457% +$1.11M 0.01% 1858
2013
Q3
$71K Sell
2,607
-1,155,154
-100% -$31.4M ﹤0.01% 3470
2013
Q2
$30.8M Buy
+1,157,761
New +$32M 0.19% 62

Other funds holding PFE

Spot Trading's PFE Position: Q3 2017 in Review

Spot Trading sold out of Pfizer (PFE) in Q3 2017, closing a stake of 41,298 shares — an estimated $1.33M sold.

Spot Trading first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $30.8M in Q2 2013. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Spot Trading reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 41,298 Pfizer shares in Q3 2017, an estimated $1.33M.
  • Spot Trading first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Spot Trading's Pfizer position peaked at $30.8M in Q2 2013.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.